INTERNATIONAL DESK: British-Swedish drug maker AstraZeneca NSE 1.67 % said it intends to apply for emergency use authorisation (EUA) of…
INTERNATIONAL DESK: British-Swedish drug maker AstraZeneca NSE 1.67 % said it intends to apply for emergency use authorisation (EUA) of…
INTERNATIONAL DESK: Biocon Biologics, a subsidiary of the Bengaluru-based pharmaceutical firm Biocon, announced on Monday it has received an “exclusive…